Association of Antidepressant Serotonin Transporter Affinity With Bleeding Events in a Veteran Population

View at publisher
Authors: Emily H. Barbour, Christie Kahlon, Marc J. Pepin, Anthony J. Finch, Tracey Holsinger, Jamie N. Brown, Frank Tillman
Cited by: 2
References: 23

Abstract

Treatment-emergent bleeding is a well-known risk with serotonergic antidepressants. Studies assessing this risk based on varying serotonergic binding affinity are limited. This report was conducted to address this gap in the literature by evaluating antidepressant-associated bleeding risks based on binding affinity to the serotonin transporter (SERT). A sample of bleeding events from 267 patients that occurred between January 1, 2018 and January 1, 2020, within a single Veterans Affairs (VA) Health Care System was retrospectively evaluated. The primary endpoint was the percentage of veterans experiencing a bleeding event while prescribed an antidepressant with high (K i ≤1), intermediate (K i >1 to

Fields of Study & Subjects

Cardiac Health and Mental Health Potassium and Related Disorders Gastrointestinal Bleeding Diagnosis and Treatment

Publication details

Journal / source
Journal of Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
46
Issue
2
Pages
134–139
Publication date
26 January 2026
Language
EN